A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

NCT07305779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SEP-380135
DRUG: Quinidine Gluconate

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.